These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 27189101
1. Spin-labelled photo-cytotoxic diazido platinum(iv) anticancer complex. Venkatesh V, Wedge CJ, Romero-Canelón I, Habtemariam A, Sadler PJ. Dalton Trans; 2016 Aug 16; 45(33):13034-7. PubMed ID: 27189101 [Abstract] [Full Text] [Related]
2. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. Zhao Y, Woods JA, Farrer NJ, Robinson KS, Pracharova J, Kasparkova J, Novakova O, Li H, Salassa L, Pizarro AM, Clarkson GJ, Song L, Brabec V, Sadler PJ. Chemistry; 2013 Jul 15; 19(29):9578-91. PubMed ID: 23733242 [Abstract] [Full Text] [Related]
3. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs. Shi H, Romero-Canelón I, Hreusova M, Novakova O, Venkatesh V, Habtemariam A, Clarkson GJ, Song JI, Brabec V, Sadler PJ. Inorg Chem; 2018 Nov 19; 57(22):14409-14420. PubMed ID: 30365308 [Abstract] [Full Text] [Related]
5. Photoactivatable diazido Pt(IV) anticancer complex can bind to and oxidize all four nucleosides. Cheng Y, Zhang J, Wu K, Gao F, Cheng Y, Zou T, Wu X, Zhao Y, Wang F. Dalton Trans; 2020 Dec 15; 49(47):17157-17163. PubMed ID: 33244530 [Abstract] [Full Text] [Related]
6. Adenine-adenine, adenine-cytosine and cytosine-cytosine intrastrand crosslinks induced by a photoactivatable Pt(IV) anticancer prodrug. Lin J, Huang J, Zhang J, Qin X, Ma Z, Wu X, Wang F, Zhao Y, Wu K. Dalton Trans; 2023 Dec 19; 53(1):292-298. PubMed ID: 38047479 [Abstract] [Full Text] [Related]
7. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug. Ma L, Lin X, Li C, Xu Z, Chan CY, Tse MK, Shi P, Zhu G. Inorg Chem; 2018 Mar 05; 57(5):2917-2924. PubMed ID: 29436828 [Abstract] [Full Text] [Related]
8. Reactions of a photoactivatable diazido Pt(iv) anticancer complex with a single-stranded oligodeoxynucleotide. Liang Z, Lin J, Gong X, Cheng Y, Huang C, Zhang J, Wu X, Wang F, Zhao Y, Wu K. Dalton Trans; 2020 Aug 18; 49(32):11249-11259. PubMed ID: 32756682 [Abstract] [Full Text] [Related]
10. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity. Yao H, Chen S, Deng Z, Tse MK, Matsuda Y, Zhu G. Inorg Chem; 2020 Aug 17; 59(16):11823-11833. PubMed ID: 32799491 [Abstract] [Full Text] [Related]
11. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells. Cetraz M, Sen V, Schoch S, Streule K, Golubev V, Hartwig A, Köberle B. Arch Toxicol; 2017 Feb 17; 91(2):785-797. PubMed ID: 27307157 [Abstract] [Full Text] [Related]
12. Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity. Spector D, Bubley A, Zharova A, Bykusov V, Skvortsov D, Ipatova D, Erofeev A, Gorelkin P, Vaneev A, Mazur D, Nikitina V, Melnikov M, Pergushov V, Bunin D, Kuzmin V, Kostyukov A, Egorov A, Beloglazkina E, Akasov R, Krasnovskaya O. ACS Appl Bio Mater; 2024 May 20; 7(5):3431-3440. PubMed ID: 38697834 [Abstract] [Full Text] [Related]
14. A Photodynamic and Photochemotherapeutic Platinum-Iridium Charge-Transfer Conjugate for Anticancer Therapy. Shi H, Carter OWL, Ponte F, Imberti C, Gomez-Gonzalez MA, Cacho-Nerin F, Quinn PD, Parker JE, Sicilia E, Huang H, Sadler PJ. Angew Chem Int Ed Engl; 2024 Jun 03; 63(23):e202400476. PubMed ID: 38656762 [Abstract] [Full Text] [Related]
15. Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism. Westendorf AF, Woods JA, Korpis K, Farrer NJ, Salassa L, Robinson K, Appleyard V, Murray K, Grünert R, Thompson AM, Sadler PJ, Bednarski PJ. Mol Cancer Ther; 2012 Sep 03; 11(9):1894-904. PubMed ID: 22710878 [Abstract] [Full Text] [Related]
17. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Thiabaud G, McCall R, He G, Arambula JF, Siddik ZH, Sessler JL. Angew Chem Int Ed Engl; 2016 Oct 04; 55(41):12626-31. PubMed ID: 27377046 [Abstract] [Full Text] [Related]
18. Photosubstitution and photoreduction of a diazido platinum(IV) anticancer complex. Shi H, Ward-Deitrich C, Ponte F, Sicilia E, Goenaga-Infante H, Sadler PJ. Dalton Trans; 2024 Aug 06; 53(31):13044-13054. PubMed ID: 39028324 [Abstract] [Full Text] [Related]
19. An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies. Gandioso A, Shaili E, Massaguer A, Artigas G, González-Cantó A, Woods JA, Sadler PJ, Marchán V. Chem Commun (Camb); 2015 Jun 04; 51(44):9169-72. PubMed ID: 25947177 [Abstract] [Full Text] [Related]
20. Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate. Vernooij RR, Joshi T, Shaili E, Kubeil M, Appadoo DR, Izgorodina EI, Graham B, Sadler PJ, Wood BR, Spiccia L. Inorg Chem; 2016 Jun 20; 55(12):5983-92. PubMed ID: 27257848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]